- Our Focus
A new era of neurological treatments
Novartis is proud to serve people living with neurological conditions around the globe. Above all, partnering with patients, healthcare professionals and healthcare systems to deliver life-changing solutions and treatments is at the core of what we do.
With a "brain in a dish," researchers take on a host of neurological disorders
Multiple sclerosis (MS) is a chronic disorder of the central nervous system. It disrupts the normal functioning of the brain, nervous system and spinal cord through inflammation of the myelin sheath which protects the nerve cells.
Migraine is a complex and distinct neurological disease. It involves recurrent attacks of moderate-to-severe head pain and is associated with nausea, vomiting and sensitivity to light, sound and odors.
Speak Your Migraine
Migraine is one of the top 10 causes of years lived with disability for men and women according to the World Health Organisation.
Speak your migraine is a platform with the key goal to empower patients by fostering a community and enable more productive conversations about migraine with their doctors and families. If you or someone you love is suffering from migraine, encourage them to speak their migraine at our Facebook page (for those outside of the United States).
It is estimated that around 44 million people globally have Alzheimer's or a related dementia. Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks of daily living. In most people with Alzheimer's, symptoms first appear after age 60. Although treatment can help manage symptoms in some people, currently there is no cure.
Novartis is currently conducting a clinical trial program targeting cognitively healthy individuals at risk to develop symptoms of Alzheimer’s disease.
There are areas of high unmet need for people suffering from neuromuscular conditions such as sarcopenia and hip fracture recovery. Additionally, we are committed to the research of peripheral neuropathic pain, a chronic and debilitating condition.